HeartBeam, Inc. has reported its financial and operational results for the second quarter of 2024, showcasing progress towards key clinical and regulatory milestones for…
Browsing: FDA
The field of companion diagnostic (CDx) development is expanding beyond oncology and into other areas such as hereditary diseases and autoimmune disorders. Machine learning…
Tejesh Marsale is a visionary engineer at the forefront of the AI and machine learning revolution in the medical technology industry. His work focuses…
Tala Fakhouri, Associate Director for Policy Analysis at the FDA, discusses the potential future of AI and machine learning in the pharmaceutical industry and…
This article discusses the potential benefits of artificial intelligence and machine learning in the medical field, with a focus on the recent update of…
Tala Fakhouri, Associate Director for Policy Analysis at the FDA, discusses the use of artificial intelligence and machine learning in drug development. She highlights…
NeuroSense and PhaseV are collaborating to use causal machine learning for clinical trial analysis and optimization of NeuroSense’s ALS therapy. The therapy, PrimeC, is…
Patient advocacy groups urge Congress to encourage CMS to formalize a payment pathway for AI and ML in medical imaging. Despite the benefits of…
iRxReminder, LLC is thrilled to announce the enrollment of its first patients in the innovative NIMH-funded study, the TDtect™ Diagnostic. This groundbreaking study leverages…
The United States’ Food and Drug Administration (FDA) has been leading the global discussions on regulatory oversight and has been a prominent example in…